Pomerantz LLP

Please read and download this complaint. When you have finished, continue to Join this ACTION >>

Questions? Contact Us

Contact Us Join This Action

Pomerantz survived defendants’ motion to dismiss this litigation against the high-profile pharmaceutical company for charges related to Mylan's alleged systemic practice of over-charging Medicaid for its Epi-pens.

Read about the case here.